How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

4,242 results for

Rh Sensitization

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. Prevention of Rh Alloimmunization

Prevention of Rh Alloimmunization No. 133-Prevention of Rh Alloimmunization - Journal of Obstetrics and Gynaecology Canada Email/Username: Password: Remember me Search Terms Search within Search Volume 40, Issue 1, Pages e1–e10 No. 133-Prevention of Rh Alloimmunization x Karen Fung Kee Fung , MD Ottawa, ON x Erica Eason , MD Ottawa, ON No. 133, Reaffirmed January 2018 DOI: To view the full text, please login as a subscribed user or . Click to view the full text on ScienceDirect. Abstract (...) Objective To provide guidelines on use of anti-D prophylaxis to optimize prevention of rhesus (Rh) alloimmunization in Canadian women. Outcomes Decreased incidence of Rh alloimmunization and minimized practice variation with regards to immunoprophylaxis strategies. Evidence The Cochrane Library and MEDLINE were searched for English-language articles from 1968 to 200 I, relating to the prevention of Rh alloimmunization. Search terms included: Rho(D) immune globulin, Rh iso- or aile-immunization, anti-D

2018 Society of Obstetricians and Gynaecologists of Canada

2. Latent toxoplasmosis and olfactory functions of Rh positive and Rh negative subjects. Full Text available with Trip Pro

Latent toxoplasmosis and olfactory functions of Rh positive and Rh negative subjects. The prevalence of toxoplasmosis is higher in schizophrenics than in the general population. It has been suggested that certain symptoms of schizophrenia, including changes in olfactory functions, are in fact symptoms of toxoplasmosis that can be easily detected in schizophrenics only due to the increased prevalence of toxoplasmosis in this population. Schizophrenics have impaired identification of odors (...) and lower sensitivity of odor detection, however, no information about these parameters of non-schizophrenic Toxoplasma-infected subjects is available.Here we searched for differences in olfactory functions between 62 infected and 61 noninfected non-schizophrenic subjects using the case-controls experimental design.The infected men scored better than the non-infected controls in the standard odor-identification test. The infected women rated all smells as more intensive while the infected men rated

2018 PLoS ONE

3. Rh sensitization in Canada is not obsolete Full Text available with Trip Pro

Rh sensitization in Canada is not obsolete 29479222 2018 11 13 1205-7088 22 4 2017 Jul Paediatrics & child health Paediatr Child Health Rh sensitization in Canada is not obsolete. 238-239 10.1093/pch/pxx076 Baker Jillian M JM Department of Pediatrics, St. Michael's Hospital, Toronto, Ontario. Division of Haematology-Oncology, The Hospital for Sick Children, Toronto, Ontario. Campbell Douglas M DM Department of Pediatrics, St. Michael's Hospital, Toronto, Ontario. Bhutani Vinod K VK Department

2017 Paediatrics & child health

4. Rh Sensitization

Rh Sensitization Rh Sensitization Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Rh Sensitization Rh Sensitization Aka: Rh (...) Sensitization , Rh Isoimmunization From Related Chapters II. Pathophysiology Maternal Formation to fetal Rh IgM (Agglutinates in ) forms in 7 days Does not cross placenta IgG (Agglutinates in Albumin) forms in 21 days Crosses placenta easily Results in Neonatal III. Indications for giving RhoGAM (xD) to Rh Negative Mother Standard Timing Week 28 gestation Postpartum (under 3 days postpartum if baby Rh+) Additional Indications Placenta Separation Labor Third Stage Termination or after 6 weeks Antepartum

2018 FP Notebook

5. Non-invasive determination of the fetal rhesus factor to prevent maternal rhesus sensitization

Non-invasive determination of the fetal rhesus factor to prevent maternal rhesus sensitization 1 Translation of Chapters 1 to 6 of the final report Nicht invasive Bestimmung des fetalen Rhesusfaktors zur Vermeidung einer mütterlichen Rhesussensibilisierung (Version 1.0; Status: 20 March 2018). Please note: This translation is provided as a service by IQWiG to English-language readers. However, solely the German original text is absolutely authoritative and legally binding. Extract IQWiG Reports (...) – Commission No. D16-01 Non-invasive determination of the fetal rhesus factor to prevent maternal rhesus sensitization 1 Extract of final report D16-01 Version 1.0 Determination of fetal rhesus factor 20 March 2018 Institute for Quality and Efficiency in Health Care (IQWiG) - i - Publishing details Publisher: Institute for Quality and Efficiency in Health Care Topic: Non-invasive determination of the fetal rhesus factor to prevent maternal rhesus sensitization Commissioning agency: Federal Joint Committee

2019 Institute for Quality and Efficiency in Healthcare (IQWiG)

6. Acetone Sensing Properties and Mechanism of Rh-Loaded WO3 Nanosheets Full Text available with Trip Pro

Acetone Sensing Properties and Mechanism of Rh-Loaded WO3 Nanosheets WO3 nanosheets was prepared by an acidification method and the Rh catalyst was dispersed on the surface of the nanosheets with a wet impregnation method. The morphology of pristine WO3 and Rh modified WO3 nanosheets and their responses to acetone gas were studied. According to oxygen adsorption combined with TPR results, the sensing and sensitization mechanism of acetone were discussed. It was found that no visible changes (...) in nanostructures or morphologies were observed in WO3 nanosheets with Rh, however, the sensor resistance and sensor response were greatly promoted. The basic sensitization mechanism could be caused by the electronic interaction between oxidized Rh and WO3 surface.

2018 Frontiers in chemistry

7. Studies of the antibody nature of the rheumatoid factor: Reaction of the rheumatoid factor with sheep erythrocytes sensitized with human anti-sheep cell antibodies and with O Rh positive cells sensitized with incomplete anti-Rh antibodies Full Text available with Trip Pro

Studies of the antibody nature of the rheumatoid factor: Reaction of the rheumatoid factor with sheep erythrocytes sensitized with human anti-sheep cell antibodies and with O Rh positive cells sensitized with incomplete anti-Rh antibodies 14193154 1996 12 01 2018 12 01 0019-2805 7 1964 Jul Immunology Immunology STUDIES OF THE ANTIBODY NATURE OF THE RHEUMATOID FACTOR. REACTION OF THE RHEUMATOID FACTOR WITH SHEEP ERYTHROCYTES SENSITIZED WITH HUMAN ANTI-SHEEP CELL ANTIBODIES AND WITH O RH POSITIVE (...) CELLS SENSITIZED WITH INCOMPLETE ANTI-RH ANTIBODIES. 403-18 AHO K K HARBOE M M LEIKOLA J J eng Journal Article England Immunology 0374672 0019-2805 0 ABO Blood-Group System 0 Antibodies 0 Antibodies, Anti-Idiotypic 0 Immunoglobulins 0 Rh-Hr Blood-Group System 0 gamma-Globulins 9009-79-4 Rheumatoid Factor OM ABO Blood-Group System Animals Antibodies Antibodies, Anti-Idiotypic Antigen-Antibody Reactions Biomedical Research Erythrocytes Hemagglutination Hemagglutination Inhibition Tests Hemolysis

1964 Immunology

8. 2016 American College of Rheumatology (ACR) - European League Against Rheumatism (EULAR) Criteria for Minimal, Moderate and Major Clinical Response for Juvenile Dermatomyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rh Full Text available with Trip Pro

2016 American College of Rheumatology (ACR) - European League Against Rheumatism (EULAR) Criteria for Minimal, Moderate and Major Clinical Response for Juvenile Dermatomyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rh To develop response criteria for adult dermatomyositis (DM) and polymyositis (PM).Expert surveys, logistic regression, and conjoint analysis were used to develop 287 definitions using core set measures. Myositis experts rated greater (...) , moderate, and major improvement were ≥20, ≥40, and ≥60 points in the total improvement score. The same criteria were chosen for juvenile DM, with different improvement thresholds. Sensitivity and specificity in DM/PM patient cohorts were 85% and 92%, 90% and 96%, and 92% and 98% for minimal, moderate, and major improvement, respectively. Definitions were validated in the clinical trial analysis for differentiating the physician rating of improvement (P < 0.001).The response criteria for adult DM/PM

2017 Arthritis & rheumatology (Hoboken, N.J.)

9. 2016 American College of Rheumatology (ACR) - European League Against Rheumatism (EULAR) Criteria for Minimal, Moderate and Major Clinical Response for Juvenile Dermatomyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rh Full Text available with Trip Pro

2016 American College of Rheumatology (ACR) - European League Against Rheumatism (EULAR) Criteria for Minimal, Moderate and Major Clinical Response for Juvenile Dermatomyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rh To develop response criteria for juvenile dermatomyositis (DM).We analyzed the performance of 312 definitions that used core set measures from either the International Myositis Assessment and Clinical Studies Group (IMACS) or the Paediatric (...) for a conjoint analysis-based continuous model with a total improvement score of 0-100, using absolute percent change in core set measures of minimal (≥30), moderate (≥45), and major (≥70) improvement. The same criteria were chosen for adult DM/polymyositis, with differing thresholds for improvement. The sensitivity and specificity were 89% and 91-98% for minimal improvement, 92-94% and 94-99% for moderate improvement, and 91-98% and 85-86% for major improvement, respectively, in juvenile DM patient cohorts

2017 Arthritis & rheumatology (Hoboken, N.J.)

10. Prevention of Rh alloimmunization in pregnant and post-partum women: a protocol for a systematic review

Prevention of Rh alloimmunization in pregnant and post-partum women: a protocol for a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files (...) cell dose (linear); blinding of outcome assessment reported (stratified yes vs no). For stratified analyses, a minimum number of 8 studies per subgroup is required. ">Subgroup analyses A sensitivity analysis is conducted to assess the impact of decisions taken in the review process on the meta-analysis outcome. These decisions may have been made in various stages of the review, e.g. the decision to exclude certain disease models, the decision to pool certain units of measurement for an outcome

2019 PROSPERO

11. Efficacy of Intravenous Immunoglobulin in Management of Rh and ABO Incompatibility Disease

in patients who are discharged from nursery and readmit with severe hyperbilirubinemia. Rh incompatibility can occur when an Rh-negative pregnant mother is exposed to Rh-positive fetal red blood cells secondary to fetomaternal hemorrhage during the course of pregnancy from spontaneous or induced abortion , trauma, invasive obstetric procedures, or normal delivery. As a consequence, blood from the fetal circulation, and, after a significant exposure, sensitization occurs leading to maternal antibody (...) Efficacy of Intravenous Immunoglobulin in Management of Rh and ABO Incompatibility Disease Efficacy of Intravenous Immunoglobulin in Management of Rh and ABO Incompatibility Disease - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more

2017 Clinical Trials

12. Titration of Antisera to Soluble Proteins on the Basis of an Agglutination Reaction: Conjugation of Egg Albumin and Chicken Serum Globulin to the Incomplete Rh Antibody and the Subsequent Use of Rh-Positive Cells, Sensitized by such Conjugated Incomplete Full Text available with Trip Pro

Titration of Antisera to Soluble Proteins on the Basis of an Agglutination Reaction: Conjugation of Egg Albumin and Chicken Serum Globulin to the Incomplete Rh Antibody and the Subsequent Use of Rh-Positive Cells, Sensitized by such Conjugated Incomplete 14954111 2004 02 15 2018 12 01 0007-1021 33 4 1952 Aug British journal of experimental pathology Br J Exp Pathol Titration of antisera to soluble proteins on the basis of an agglutination reaction: conjugation of egg albumin and chicken serum (...) globulin to the incomplete Rh antibody and the subsequent use of Rh-positive cells, sensitized by such conjugated incomplete antibodies, to titrate antisera against egg albumin and chicken globulin. 390-7 COOMBS R R A RR HOWARD A N AN WILD F F eng Journal Article England Br J Exp Pathol 0372543 0007-1021 0 Albumins 0 Immune Sera 0 Rh-Hr Blood-Group System 0 Rho(D) Immune Globulin 0 Serum Globulins OM Agglutination Agglutination Tests Albumins Animals Chickens Humans Immune Sera Rh-Hr Blood-Group System

1952 British journal of experimental pathology

13. Controlled trial of various anti-D dosages in suppression of Rh sensitization following pregnancy. Report to the Medical Research Council by the working party on the use of anti-D-immunoglobulin for the prevention of isoimmunization of Rh-negative women d Full Text available with Trip Pro

Controlled trial of various anti-D dosages in suppression of Rh sensitization following pregnancy. Report to the Medical Research Council by the working party on the use of anti-D-immunoglobulin for the prevention of isoimmunization of Rh-negative women d In a controlled trial phials containing 200 mug, 100 mug, 50 mug, or 20 mug of IgG anti-D were given to nearly 2,000 D-negative primiparae whose infants were D-positive and ABO-compatible. Only mothers whose serum lacked anti-D were included

1974 British medical journal Controlled trial quality: uncertain

14. Cost-effectiveness of adding rh-endostatin to first-line chemotherapy in patients with advanced non-small-cell lung cancer in China

Cost-effectiveness of adding rh-endostatin to first-line chemotherapy in patients with advanced non-small-cell lung cancer in China Cost-effectiveness of adding rh-endostatin to first-line chemotherapy in patients with advanced non-small-cell lung cancer in China Cost-effectiveness of adding rh-endostatin to first-line chemotherapy in patients with advanced non-small-cell lung cancer in China Wu B, Chen H, Shen J, Ye M Record Status This is a critical abstract of an economic evaluation (...) was unlikely to be cost-effective when added to standard chemotherapy; however, at a high willingness to pay, it might be a cost-effective treatment option. Although the reporting of a few items in the study could have been better, the authors' conclusions appear appropriate. Type of economic evaluation Cost-effectiveness analysis, cost-utility analysis Study objective The study estimated the effects of adding a new recombinant-human (rh) endostatin to standard first-line platinum-based chemotherapy

2011 NHS Economic Evaluation Database.

15. Does Rh immune globulin suppress HLA sensitization in pregnancy? Full Text available with Trip Pro

Does Rh immune globulin suppress HLA sensitization in pregnancy? How Rh immune globulin (RhIG) prevents sensitization to D antigen is unclear. If RhIG Fc delivers a nonspecific immunosuppressive signal, then RhIG may inhibit sensitization to antigens other than D. HLA antibody prevalence was compared in previously pregnant D- versus D+ women to investigate whether RhIG suppresses HLA sensitization.In the Leukocyte Antibody Prevalence Study (LAPS), 7920 volunteer blood donors were screened (...) for anti-HLA and surveyed about prior pregnancies and transfusions. A secondary analysis of the LAPS database was performed.D- women not more than 40 years old (presumed to have received antenatal with or without postpartum RhIG in all pregnancies) had a significantly lower HLA sensitization rate than D+ women (relative risk, 0.58; 95% confidence interval [CI], 0.40-0.83). When stratified by deliveries (one, two, three, or four or more), D- women not older than 40 were HLA sensitized less often than D

2013 Transfusion

16. Systematic review of Rh immunoprophylaxis after vaginal bleeding in the first trimester

Systematic review of Rh immunoprophylaxis after vaginal bleeding in the first trimester Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing (...) A sensitivity analysis is conducted to assess the impact of decisions taken in the review process on the meta-analysis outcome. These decisions may have been made in various stages of the review, e.g. the decision to exclude certain disease models, the decision to pool certain units of measurement for an outcome, the choice of effect measure, how subgroup variables are stratified etc. In order to assess the robustness of the findings of the meta-analysis, the analyses are re-run using the alternative

2017 PROSPERO

17. Rh Sensitization

Rh Sensitization Rh Sensitization Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Rh Sensitization Rh Sensitization Aka: Rh (...) Sensitization , Rh Isoimmunization From Related Chapters II. Pathophysiology Maternal Formation to fetal Rh IgM (Agglutinates in ) forms in 7 days Does not cross placenta IgG (Agglutinates in Albumin) forms in 21 days Crosses placenta easily Results in Neonatal III. Indications for giving RhoGAM (xD) to Rh Negative Mother Standard Timing Week 28 gestation Postpartum (under 3 days postpartum if baby Rh+) Additional Indications Placenta Separation Labor Third Stage Termination or after 6 weeks Antepartum

2015 FP Notebook

18. Non-inferiority of Immunoglobulin Anti-RhD KamRho-D® Compared to Rhopphylac® in Postpartum Immunization of Rh-negative, Coombs Negative Women at Risk of Sensitization.

Non-inferiority of Immunoglobulin Anti-RhD KamRho-D® Compared to Rhopphylac® in Postpartum Immunization of Rh-negative, Coombs Negative Women at Risk of Sensitization. Clinical Efficacy of Postpartum Immunization of Rh and Coombs Negative Women With Sensitization Risk. - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning (...) You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Clinical Efficacy of Postpartum Immunization of Rh and Coombs Negative Women With Sensitization Risk. The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT01666249 Recruitment Status

2012 Clinical Trials

19. Salt Sensitivity of Blood Pressure Full Text available with Trip Pro

Salt Sensitivity of Blood Pressure Salt Sensitivity of Blood Pressure | Hypertension Search Hello Guest! Login to your account Email Password Keep me logged in Search April 2019 March 2019 February 2019 January 2019 This site uses cookies. By continuing to browse this site you are agreeing to our use of cookies. Free Access article Share on Jump to Free Access article Salt Sensitivity of Blood Pressure A Scientific Statement From the American Heart Association , MD, FAHA, Vice Chair , MD, FAHA (...) and on behalf of the American Heart Association Professional and Public Education Committee of the Council on Hypertension; Council on Functional Genomics and Translational Biology; and Stroke Council Originally published 21 Jul 2016 Hypertension. 2016;68:e7–e46 You are viewing the most recent version of this article. Previous versions: Introduction The simplest definition of salt sensitivity of blood pressure (SSBP) states that it is a physiological trait present in rodents and other mammals, including

2016 American Heart Association

20. A state program for prevention of sensitization to Rh factor. Full Text available with Trip Pro

A state program for prevention of sensitization to Rh factor. 4100803 1971 04 26 2018 11 13 0083-1204 86 3 1971 Mar HSMHA health reports HSMHA Health Rep A state program for prevention of sensitization to Rh factor. 212-6 Umansky I I Worth D J DJ Benjamin R R Madoff M A MA Edsall G G Diamond L K LK eng Journal Article United States HSMHA Health Rep 0323220 0083-1204 0 Rh-Hr Blood-Group System 0 gamma-Globulins AIM IM Antibody Formation Blood Donors Erythroblastosis, Fetal prevention & control (...) Female Humans Infant, Newborn Male Massachusetts Plasmapheresis Pregnancy Public Health Administration Rh-Hr Blood-Group System gamma-Globulins therapeutic use 1971 3 1 1971 3 1 0 1 1971 3 1 0 0 ppublish 4100803 PMC1937083 Science. 1966 Feb 18;151(3712):828-30 17746731 N Engl J Med. 1963 Dec 19;269:1344-8 14064318 Vox Sang. 1958 Sep;3(5):321-30 13604117 N Engl J Med. 1954 Sep 16;251(12):453-9 13194094 J Am Med Assoc. 1954 Jul 31;155(14):1209-13 13174377 N Engl J Med. 1951 Jan 11;244(2):39-49 14785788

1971 HSMHA Health Reports

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>